Where Are All the AI Drugs?

The article discusses the potential of AI in the pharmaceutical industry, where drug development is notoriously challenging. Despite the high failure rate of traditional drug candidates, a few startups are turning to AI in the hopes of improving the success rate. The article highlights that while AI has shown promise in various industries, its application in drug discovery and development has been slower to materialize. Challenges include the complexity of biological systems, the need for large datasets, and the difficulty in translating AI insights into viable drug candidates. The article also notes that while some AI-powered drug candidates have entered clinical trials, the industry is still waiting for the first AI-developed drug to reach the market. The article suggests that the true impact of AI in this field may take several more years to become fully evident. Overall, the article provides a balanced perspective on the current state of AI in the pharmaceutical industry, acknowledging both the potential and the ongoing challenges facing startups and researchers in this field.